Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, July 12, 2010

Cancer drug olaparib (PARP inhibitor) shows early promise | Philadelphia Inquirer (BRCA 1/2)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.